Background
Normothermic regional perfusion (NRP) is a technique that restores warm, oxygen-rich blood flow to selected organs after death has been declared to help preserve them for transplantation.
In September 2024, HRSA directed the OPTN to investigate potential policy violations related to NRP and develop standards to protect patients and improve donor families’ experiences.
The OPTN Board of Directors approved the NRP Policy through an emergency action so urgent safety safeguards could take effect immediately, with additional requirements implemented in phases. The policy will still undergo public comment and may be updated based on feedback.
Sponsors: OPTN Board of Directors and NRP Workgroup
Public Comment Period: Nov. 13 - Dec. 28, 2026
Board Approved: TBD
Effective Date: Phased implementation as outlined below
Summary of policy changes
The Board-approved policy establishes new and enhanced safeguards for patient safety, authorization and disclosure, communication, and accountability. It:
- Clarifies and reorganizes required steps for organ procurement organizations (OPOs) to better reflect the stages of the organ donation and procurement process.
- Strengthens the information that must be disclosed to donors or their agents.
- Establishes requirements for using NRP in controlled donation after circulatory death (DCD).
- Adds reporting requirements for NRP procedure details and any potential patient safety events.
Phased implementation
Implementation begins immediately, with requirements taking effect in phases to prioritize urgent safety protections and allow time for operational changes needed to support additional requirements.
Phase 1 (tentatively 30 days after Board approval)
Surgical techniques
- NRP must not begin until after 5 minutes have elapsed after pulselessness and the donor is pronounced dead by the hospital patient care team
- The NRP team must take all necessary steps to prevent blood flow to the brain (secure, transect, and vent blood vessels at risk of perfusing the brain)
- Paralytic agents must not be used in the context of NRP
Routine documentation
- For all actual/attempted recoveries using NRP, OPO must upload DCD flowsheet and operative note within 24 hours (requirement expands to include documentation of pre-withdrawal huddle when this is implemented)
Reporting requirements for patient safety events
- Reportable events: (1) Pre-mortem cannulation is performed and the patient’s death does not occur within the expected time frame; (2) An unplanned pause is requested due to concern that perfusion may have been restored to the brain.
- Reportable events: There is withdrawal of life-sustaining support prior to the pre-recovery huddle
Phase 2 (tentatively 3-6 months after public comment)
Communication requirements
- Pre-departure huddle:
- Includes OPO representative and lead surgeons from procurement and NRP teams
- Participants review surgical approach and verify surgical team members who will be present
- Prior to withdrawal of life sustaining therapy (WLST) huddle:
- Includes OPO staff, donor hospital operating room staff, surgical procurement team, and NRP team
- Participants (1) review how to raise concerns, how to initiate an unplanned pause, surgical approach; and (2) confirm plan for how patient care will be transferred back to the hospital healthcare team if a concern is raised
Authorization requirements
- Pre-mortem procedures (e.g., cannulation) require consent of the donor or donor’s agent
- OPOs may have a separate authorization form for NRP or include NRP authorization in their standard authorization form for organ donation
- Disclosures regarding NRP must include the following information:
- NRP is performed to increase the likelihood that the organs will be utilized for transplant
- NRP restores perfusion to certain organs, and those organs are expected to resume function
- There is a potential risk of restoring blood flow to the donor’s brain; the team will make every effort to prevent this from happening
Documentation of plan to return donor to the care of the hospital
- OPOs must have a documented plan for how patient care will be transferred back to the hospital healthcare team if concerns arise for cerebral perfusion or other physical responses during the NRP process
The OPTN will provide implementation notices, guidance, and educational resources to help members meet the requirements as each phase takes effect.
Resources
- Proposed Policy (PDF - 936 KB)*
- Board Decision Presentation (PDF - 693 KB)*
- Announcement of Board Approval of the NRP Policy
*If you use assistive technology, you may not be able to access information in these files. For help, contact us at 800-221-9393.
Questions for Consideration
The Workgroup welcomes community feedback on all aspects of the proposal and offers the following questions for consideration:
- The OPTN policies reference the term “time of cross-clamp” in OPTN Policy 2.15.D.i Process for a Pause. Clamp time is defined on the OPTN website as “The time at which the flow of blood to a particular organ has been clamped off during a procurement.” Is this definition sufficient and aligned appropriately with the intentions of NRP policy?
- OPTN Members are responsible for complying with all OPTN Obligations, per OPTN Management and Membership Policy F.1.e Member Compliance, which include acting to avoid risks to patient health or public safety. Do you agree that policy should specify the following: In the event that there are questions about whether the potential donor is exhibiting signs of life, OPO providers and relevant staff must remain in the room until the patient care team is available to receive patient hand-off.
- Do the potential metrics of interest in Exhibit 1 adequately capture initiation and stoppage of NRP? What additional metrics should the OPTN consider monitoring at the time on circuit for NRP? How can the OPTN monitor that action is taken to halt NRP “without delay” or “within a short period of time” when signs of life are observed during the NRP process?
Public comments open
The public may submit comments on this policy proposal from November 13 through December 28, 2026. HRSA staff will review the comments and post them on this page within two to three business days.
Submit a Comment
There are 3 specific questions for consideration by the committee on p10 of the proposal.
1) Time to cross-clamp is an adequate definition as proposed.
I am deeply troubled by the two inter-related proposals that follows (assuming this is related to the process of NRP):
Although I agree with the premise that the OPO and providers must remain in the room until patient's primary care team is available for handoff, the proposal is incredibly nebulous and confusing. At best questions both the practicality of such a policy and the ethical aspects that surround the process. It seems that it was weaved together without any thought as what has ACTUALLY happened in the OR up to that point.
Please consider this real setting and the sequence of events preceding "signs of life":
A) the patient has been pronounced dead
B) The chest has been opened fast
C) The cerebral vessels have been severed and vented
D) Cannulation has occurred and the patient is on bypass, fully heparinized
In this condition someone makes an observation that the patient has "signs of life" which is vaguely defined, can be called by anyone, and may or may not be verifiable. What is sign of life?how do most folks in the room, most likely not neurologic experts, have the qualification to say this? This in general is a horrible and imperfect and inadequate proposal.
Now, assuming someone calls out something they have seen as "sign of life" (we are empowering everyone in the name of patient safety concerns to be able to do that). Then what? stop, and take the patient off bypass, close the chest, likely with no anesthesia, put wires in the sternum and needles to close the patient and "hand over the patient to the primary care team? What part of this is humane and meant to protect the patient?what part of this is ethical?
Should the proposal instead consider the rapid and immediate administration of analgesics and anesthetics?This may sound as if it's "hastening death", or it's against the over-extended definition of the death donor rule. Yet I see this as the most humane approach to a very vaguely defined observation of "sign of life".
Organ harvesting should be banned outright. EVERYONE knows you need the person alive when you harvest and you give paralytics to STOP THEM from moving... but they still feel pain and are ALIVE. JUST because you can do something like harvest organs does not mean you SHOULD. THIS goes against the Oath you take do DO NO HARM.
I am a surgical intensivist who has managed organ donors and organ recipients for >30 years. I see the need for considering NRP to increase the number of potential donors, but we have to proceed with the right guardrails.
I've been involved in a number of cases of donation after circulatory determination of death. Declaring a patient dead, either via neurologic or circulatory determination, is one of the most important decisions that we, as intensivists, must make. I still get anxious about this declaration as I don't want to be wrong. Consequently, it's very disturbing to me when I hear about cases during which mistakes are made. This is an unthinkably tragic event for both the patient and the family. It also causes moral distress for all members of the healthcare team. As a healthcare community, we lose the public's trust when these incidents occur. Death is not something that we should get wrong.
Given all these issues, I wholeheartedly support the proposed policy. My only question is why a phased approach is needed. Why can't Phase 2 start at the same time as Phase 1? Should there be a moratorium on NRP until all of these policy items are in place? Such a move could help with restoring public trust.
Hopefully this policy will prevent any future catastrophic errors and allow NRP to responsibly provide desperately needed donor organs.
Public Comment in Support of Advanced Organ Donation and Normothermic Regional Perfusion (NRP) Frameworks
To the Review Committee:
As an anesthesiologist by training, dedicated to critical care, resuscitation, and organ preservation, I am writing in strong support of regulatory frameworks that enable and support Normothermic Regional Perfusion (NRP).
The reality of organ transplantation is stark. With more than 100,000 patients currently on the national transplant waiting list and fifteen lives lost every single day while waiting, we cannot afford to leave viable, life-saving organs unrecovered. NRP represents a monumental clinical advance in donation after circulatory death (DCD), restoring warm, oxygenated blood flow in situ to dramatically improve graft function and expand the usable donor pool—significantly increasing overall organ yield and providing a vital bridge for patients in end-stage organ failure.
Public awareness and high-profile advocacy underscore just how urgent this mission is for our communities. When public figures and beloved athletes—such as former Ohio State Buckeye and NFL All-Pro center Nick Mangold—courageously share their journeys with chronic kidney disease and the realities of the transplant waitlist, it brings national attention to the profound human cost of organ shortages. Stories like Nick's remind us that behind every statistic is a father, a teammate, a community pillar, and a family praying for a second chance at life.
While rigorous ethical oversight, transparency, and strict adherence to protocols are vital to maintaining public trust, we must ensure that regulatory hurdles do not inadvertently impede clinical innovation. NRP provides a medically sound, ethically responsible pathway that transforms tragedy into life-saving hope.
Thank you for your dedication to modernizing these guidelines and maximizing the life-saving potential of every donation.
Sincerely,
Jason J. Begalke, DO
NRP has always been ethically and legally problematic because NRP donors are not actually dead.
The NRP technique plays fast and loose with the legal definitions of death under the UDDA: first, death is declared as the IRREVERSIBLE cessation of circulatory and respiratory functions; but because doctors are planning to re-start the heart (showing that its cessation was not actually irreversible after all) they clamp/slit the arteries to the brain in order to make the person brain dead on purpose.
The fact that the U.S. transplant system has continued to promote NRP organ procurement despite multiple medical, ethical, and legal concerns shows a grave lack of respect for people registering in good faith to become organ donors.
NRP donors are not biologically dead at the time that their organs are procured. The desire for more transplantable organs does not justify violating the dead donor rule and taking organs from people who are not dead.